Search

everythinglearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Minoxidil's absorption is too variable for it to be a reliable reference drug.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Targeting ornithine decarboxylase can help prevent skin cancer.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.